CONMED (CNMD) Competitors $50.04 -1.23 (-2.40%) Closing price 07/14/2025 03:59 PM EasternExtended Trading$51.94 +1.90 (+3.80%) As of 07/14/2025 05:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock CNMD vs. MMSI, GKOS, BLCO, NARI, IRTC, SLNO, TMDX, INSP, NVST, and PRCTShould you be buying CONMED stock or one of its competitors? The main competitors of CONMED include Merit Medical Systems (MMSI), Glaukos (GKOS), Bausch + Lomb (BLCO), Inari Medical (NARI), iRhythm Technologies (IRTC), Soleno Therapeutics (SLNO), TransMedics Group (TMDX), Inspire Medical Systems (INSP), Envista (NVST), and PROCEPT BioRobotics (PRCT). These companies are all part of the "medical" sector. CONMED vs. Its Competitors Merit Medical Systems Glaukos Bausch + Lomb Inari Medical iRhythm Technologies Soleno Therapeutics TransMedics Group Inspire Medical Systems Envista PROCEPT BioRobotics CONMED (NYSE:CNMD) and Merit Medical Systems (NASDAQ:MMSI) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk and analyst recommendations. Which has more volatility and risk, CNMD or MMSI? CONMED has a beta of 1.2, indicating that its share price is 20% more volatile than the S&P 500. Comparatively, Merit Medical Systems has a beta of 0.65, indicating that its share price is 35% less volatile than the S&P 500. Do institutionals and insiders have more ownership in CNMD or MMSI? 99.7% of Merit Medical Systems shares are held by institutional investors. 3.1% of CONMED shares are held by company insiders. Comparatively, 3.7% of Merit Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Is CNMD or MMSI more profitable? CONMED has a net margin of 9.02% compared to Merit Medical Systems' net margin of 8.81%. Merit Medical Systems' return on equity of 15.52% beat CONMED's return on equity.Company Net Margins Return on Equity Return on Assets CONMED9.02% 14.36% 5.86% Merit Medical Systems 8.81%15.52%8.72% Which has better valuation and earnings, CNMD or MMSI? CONMED has higher earnings, but lower revenue than Merit Medical Systems. CONMED is trading at a lower price-to-earnings ratio than Merit Medical Systems, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCONMED$1.31B1.18$132.42M$3.8013.17Merit Medical Systems$1.36B4.07$120.36M$2.0445.81 Does the media prefer CNMD or MMSI? In the previous week, Merit Medical Systems had 10 more articles in the media than CONMED. MarketBeat recorded 13 mentions for Merit Medical Systems and 3 mentions for CONMED. Merit Medical Systems' average media sentiment score of 1.22 beat CONMED's score of 0.91 indicating that Merit Medical Systems is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment CONMED 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Merit Medical Systems 9 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate CNMD or MMSI? CONMED currently has a consensus target price of $62.20, suggesting a potential upside of 24.31%. Merit Medical Systems has a consensus target price of $109.11, suggesting a potential upside of 16.76%. Given CONMED's higher probable upside, equities research analysts plainly believe CONMED is more favorable than Merit Medical Systems.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CONMED 0 Sell rating(s) 4 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.20Merit Medical Systems 0 Sell rating(s) 1 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 2.89 SummaryMerit Medical Systems beats CONMED on 11 of the 16 factors compared between the two stocks. Get CONMED News Delivered to You Automatically Sign up to receive the latest news and ratings for CNMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CNMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CNMD vs. The Competition Export to ExcelMetricCONMEDMED/DENTAL IndustryMedical SectorNYSE ExchangeMarket Cap$1.55B$15.61B$5.54B$20.67BDividend Yield1.56%1.44%5.01%3.71%P/E Ratio13.1718.5528.6927.86Price / Sales1.182.31373.1756.13Price / Cash7.6317.5824.7217.92Price / Book1.613.798.254.60Net Income$132.42M$430.42M$3.19B$989.89M7 Day Performance-3.52%-1.25%5.59%1.17%1 Month Performance-6.53%2.40%9.57%5.50%1 Year Performance-26.78%16.22%30.64%10.59% CONMED Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CNMDCONMED4.3499 of 5 stars$50.04-2.4%$62.20+24.3%-26.8%$1.55B$1.31B13.173,900MMSIMerit Medical Systems4.3266 of 5 stars$91.12-2.6%$109.11+19.7%+8.2%$5.39B$1.36B44.677,400GKOSGlaukos4.3513 of 5 stars$101.69-1.7%$134.67+32.4%-13.8%$5.81B$383.48M-42.91780BLCOBausch + Lomb3.0482 of 5 stars$13.83-0.4%$15.54+12.4%-14.3%$4.89B$4.83B-13.4313,500NARIInari Medical0.2692 of 5 stars$79.97flat$69.22-13.4%N/A$4.68B$493.63M-59.24800IRTCiRhythm Technologies1.0486 of 5 stars$139.22-2.3%$138.60-0.4%+44.4%$4.44B$591.84M-44.342,000SLNOSoleno Therapeutics4.6024 of 5 stars$85.27-1.6%$107.10+25.6%+73.6%$4.30BN/A-18.4630Analyst ForecastTMDXTransMedics Group1.4362 of 5 stars$125.17-3.1%$127.33+1.7%-17.8%$4.23B$441.54M92.04210Positive NewsAnalyst RevisionINSPInspire Medical Systems4.8813 of 5 stars$127.11-1.1%$211.91+66.7%-6.3%$3.75B$802.80M58.581,246Positive NewsAnalyst UpgradeNVSTEnvista3.2639 of 5 stars$19.66-3.6%$20.23+2.9%+25.0%$3.33B$2.51B-3.0112,300PRCTPROCEPT BioRobotics2.2877 of 5 stars$56.97-1.6%$90.00+58.0%-16.1%$3.15B$224.50M-33.51430Analyst Downgrade Related Companies and Tools Related Companies MMSI Competitors GKOS Competitors BLCO Competitors NARI Competitors IRTC Competitors SLNO Competitors TMDX Competitors INSP Competitors NVST Competitors PRCT Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CNMD) was last updated on 7/15/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could...Brownstone Research | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CONMED Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share CONMED With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
